TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer

[1] Antoni S(2016)Bladder cancer incidence and mortality: a global overview and recent trends Eur. Urol. 71 96-108

[2] Bellmunt J(2017)A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now Cancer Treat. Rev. 54 58-67

[3] Powles T(2015)Emerging therapeutic targets in bladder cancer Cancer Treat. Rev. 41 170-178

[4] Vogelzang NJ(2015)Targeting signaling transduction pathways in bladder cancer Curr. Oncol. Rep. 17 244ra91-2626

[5] Carneiro BA(2014)EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype Sci. Transl. Med. 6 2619-83

[6] Abbosh PH(1995)Overexpression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation Oncogene 11 35-785

[7] McConkey DJ(2008)TAM receptor tyrosine kinase: biological functions, signaling, and potential theraputics targeting in human cancer Adv. Cancer Res. 100 769-1245

[8] Plimack ER(2014)The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer Nat. Rev. Cancer 14 1235-1784

[9] Rebouissou S(2017)Molecular insights of Gas6/TAM in cancer development and therapy Cell Death Dis. 8 1776-193

[10] Taylor IC(2014)Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes Cell Rep. 9 e8163-556

[1] Antoni S(2016)Bladder cancer incidence and mortality: a global overview and recent trends Eur. Urol. 71 96-108

[2] Bellmunt J(2017)A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now Cancer Treat. Rev. 54 58-67

[3] Powles T(2015)Emerging therapeutic targets in bladder cancer Cancer Treat. Rev. 41 170-178

[4] Vogelzang NJ(2015)Targeting signaling transduction pathways in bladder cancer Curr. Oncol. Rep. 17 244ra91-2626

[5] Carneiro BA(2014)EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype Sci. Transl. Med. 6 2619-83

[6] Abbosh PH(1995)Overexpression of the Sky receptor tyrosine kinase at the cell surface or in the cytoplasm results in ligand-independent activation Oncogene 11 35-785

[7] McConkey DJ(2008)TAM receptor tyrosine kinase: biological functions, signaling, and potential theraputics targeting in human cancer Adv. Cancer Res. 100 769-1245

[8] Plimack ER(2014)The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer Nat. Rev. Cancer 14 1235-1784

[9] Rebouissou S(2017)Molecular insights of Gas6/TAM in cancer development and therapy Cell Death Dis. 8 1776-193

[10] Taylor IC(2014)Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes Cell Rep. 9 e8163-556